Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$155.97 - $200.09 $2,963 - $3,801
-19 Reduced 1.58%
1,186 $204,000
Q1 2022

May 05, 2022

SELL
$181.39 - $234.03 $276,438 - $356,661
-1,524 Reduced 55.84%
1,205 $227,000
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $63,917 - $81,519
330 Added 13.76%
2,729 $666,000
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $244,941 - $271,338
1,294 Added 117.1%
2,399 $466,000
Q2 2021

Aug 10, 2021

BUY
$155.9 - $187.99 $172,269 - $207,728
1,105 New
1,105 $206,000
Q3 2020

Nov 09, 2020

SELL
$137.1 - $165.37 $83,768 - $101,041
-611 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$111.92 - $142.53 $14,997 - $19,099
134 Added 28.09%
611 $84,000
Q1 2020

May 07, 2020

SELL
$92.66 - $144.94 $22,053 - $34,495
-238 Reduced 33.29%
477 $56,000
Q4 2019

Feb 14, 2020

BUY
$116.25 - $133.25 $116 - $133
1 Added 0.14%
715 $95,000
Q3 2019

Nov 06, 2019

BUY
$112.57 - $128.43 $12,157 - $13,870
108 Added 17.82%
714 $89,000
Q2 2019

Aug 14, 2019

SELL
$97.98 - $114.28 $129,921 - $151,535
-1,326 Reduced 68.63%
606 $69,000
Q1 2019

May 13, 2019

BUY
$81.56 - $100.67 $157,573 - $194,494
1,932 New
1,932 $195,000
Q1 2019

May 03, 2019

SELL
$81.56 - $100.67 $163,935 - $202,346
-2,010 Closed
0 $0
Q4 2018

Feb 01, 2019

BUY
$79.28 - $95.27 $25,290 - $30,391
319 Added 18.86%
2,010 $172,000
Q2 2018

Aug 03, 2018

BUY
$79.9 - $89.2 $105,468 - $117,744
1,320 Added 355.8%
1,691 $144,000
Q1 2018

Apr 23, 2018

BUY
$71.51 - $84.69 $7,508 - $8,892
105 Added 39.47%
371 $31,000
Q4 2017

Feb 12, 2018

BUY
$63.24 - $72.8 $5,501 - $6,333
87 Added 48.6%
266 $19,000
Q3 2017

Nov 01, 2017

BUY
$59.73 - $65.4 $10,691 - $11,706
179
179 $11,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Financial Architects, Inc Portfolio

Follow Financial Architects, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.